Literature DB >> 30184760

Fabrication of a new superparamagnetic metal-organic framework with core-shell nanocomposite structures: Characterization, biocompatibility, and drug release study.

Ahmad Khajeh Ebrahimi1, Mahmood Barani2, Iran Sheikhshoaie2.   

Abstract

The Superparamagnetic CoFe2O4NPs@Mn-Organic Framework core-shell nanocomposites that had potential application in targeted drug-delivery were synthesized by layer to layer method. The structure and composition of the obtained microspheres were characterized by SEM, TEM, DLS, XRD, VSM, FTIR, and TG analysis. Results showed that the structures have a high degree crystalline, high temperature stability, magnetics and core-shell nanocomposites. Therefore, it is an excellent candidate for drug delivery systems. Afterwards, Daunorubicin (as a drug model) was laden in the MOFs by a Simple stirring. For comparison of magnetic properties of MOFs for drug delivery, an external magnetic field applied to the plate to evaluate the efficiency. The external magnetic field significantly increases anti-tumor activity of formulation (drug+ MOFs). The results showed that MOFs are biocompatible, which endue MOFs great potential in targeting drug-delivery systems with enhanced efficiency.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CoFe(2)O(4)NPs; CoFe(2)O(4)NPs@Mn-organic frameworks; Core-shell nanocomposites; Metal-organic framework; Targeted drug-delivery

Mesh:

Substances:

Year:  2018        PMID: 30184760     DOI: 10.1016/j.msec.2018.07.010

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  8 in total

1.  Diosgenin-loaded niosome as an effective phytochemical nanocarrier: physicochemical characterization, loading efficiency, and cytotoxicity assay.

Authors:  Mohammad Reza Hajizadeh; Najmeh Parvaz; Mahmood Barani; Alireza Khoshdel; Mohammad Ali Fahmidehkar; Mehdi Mahmoodi; Masoud Torkzadeh-Mahani
Journal:  Daru       Date:  2019-05-27       Impact factor: 3.117

2.  Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer.

Authors:  Mahmood Barani; Mohammad Mirzaei; Masoud Torkzadeh-Mahani; Mohammad Hadi Nematollahi
Journal:  Daru       Date:  2018-07-27       Impact factor: 3.117

Review 3.  Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma.

Authors:  Rabia Arshad; Mahmood Barani; Abbas Rahdar; Saman Sargazi; Magali Cucchiarini; Sadanand Pandey; Misook Kang
Journal:  Biosensors (Basel)       Date:  2021-03-26

Review 4.  Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update.

Authors:  Mehrdad Afarid; Shirin Mahmoodi; Roghayyeh Baghban
Journal:  J Nanobiotechnology       Date:  2022-08-02       Impact factor: 9.429

Review 5.  Nanotechnology in Bladder Cancer: Diagnosis and Treatment.

Authors:  Mahmood Barani; Seyedeh Maryam Hosseinikhah; Abbas Rahdar; Leila Farhoudi; Rabia Arshad; Magali Cucchiarini; Sadanand Pandey
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

6.  In vitro cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents.

Authors:  Mohammad Reza Hajizadeh; Haniyeh Maleki; Mahmood Barani; Mohammad Ali Fahmidehkar; Mehdi Mahmoodi; Masoud Torkzadeh-Mahani
Journal:  Res Pharm Sci       Date:  2019-10-04

7.  Biochemical, Ameliorative and Cytotoxic Effects of Newly Synthesized Curcumin Microemulsions: Evidence from In Vitro and In Vivo Studies.

Authors:  Abbas Rahdar; Mohammad Reza Hajinezhad; Saman Sargazi; Maryam Zaboli; Mahmood Barani; Francesco Baino; Muhammad Bilal; Esmael Sanchooli
Journal:  Nanomaterials (Basel)       Date:  2021-03-23       Impact factor: 5.076

Review 8.  Nanomaterials for the Diagnosis and Treatment of Inflammatory Arthritis.

Authors:  Seyedeh Maryam Hosseinikhah; Mahmood Barani; Abbas Rahdar; Henning Madry; Rabia Arshad; Vahideh Mohammadzadeh; Magali Cucchiarini
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.